
Sibira Pharma Private Limited
About Sibira Pharma Private Limited
Data last updated:
Sibira Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 05 September 2022.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2022PTC166314.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Divya Balasubramanian and Payel Sarkar.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at H No.1119 &1121 Sy No.165 Phase – V Dhoolapally Road Adj. Jeedimetla, Hyderabad, Telangana, India – 500055.
Company details
Contact details
Sibira Pharma Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressH No.1119 &1121 Sy No.165 Phase – V Dhoolapally Road Adj. Jeedimetla, Hyderabad, Telangana, India – 500055
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Sibira Pharma Private Limited
FY 2023 filings availableFinancial Statement Summary
| Metrics | FY 2022-23 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2022-23 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Sibira Pharma Private Limited, buy the company report.
Board of directors of Sibira Pharma Private Limited
Sibira Pharma has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Divya Balasubramanian | Director | 05 Sep 2022 | 4 Years 2 Months | Current |
| Bandi Chandana Also directs: Anukarna Lifesciences Private Limited | Additional Director | 27 Jan 2024 | 2 Years 9 Months | Current |
| Payel Sarkar | Director | 05 Sep 2022 | 4 Years 2 Months | Current |
| Sangarappan Sivakumar Also directs: SSK Infraprojects LLP, Pharmasyn Drugs & Intermediates Private Limited, SSK Materials Private Limited and 1 more | Director | 05 Sep 2022 | 4 Years 2 Months | Current |
Legal cases
No court or tribunal cases involving Sibira Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sibira Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Sibira Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Sibira Pharma Private Limited has 4 board changes on record since 2022: 4 appointments. The latest: Bandi Chandana was appointed as Additional Director on 27 Jan 2024.
Frequently asked questions
Sibira Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 05 September 2022 (4+ years old) and is registered under CIN U24239TG2022PTC166314.
Sibira Pharma has 4 current directors:
- Divya Balasubramanian - Director
- Bandi Chandana - Additional Director
- Payel Sarkar - Director
- Sangarappan Sivakumar - Director
The latest financial statements of Sibira Pharma on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Sibira Pharma is U24239TG2022PTC166314. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sibira Pharma was incorporated on 05 September 2022, making it 4+ years old. It is registered with the Registrar of Companies, Hyderabad.
Bandi Chandana was appointed as Additional Director on 27 Jan 2024. Divya Balasubramanian was appointed as Director on 05 Sep 2022. Payel Sarkar was appointed as Director on 05 Sep 2022. Sibira Pharma has 4 board changes on record in total.
The registered office of Sibira Pharma is at H No.1119 &1121 Sy No.165 Phase – V Dhoolapally Road Adj. Jeedimetla, Hyderabad, Telangana, India – 500055.
Sibira Pharma operates in the chemicals industry, in the manufacturing segment.
Sibira Pharma can be reached at its registered office: H No.1119 &1121 Sy No.165 Phase – V Dhoolapally Road Adj. Jeedimetla, Hyderabad, Telangana, India – 500055.
Sibira Pharma is registered under the jurisdiction of the Registrar of Companies (ROC), Hyderabad.

